Horizon Pharma PLC (NASDAQ:HZNP) has had a recent misstep on its hands with a Phase 3 flop in its Actimmune Friedrich’s Ataxia (FA) …
Akorn, Inc. (NASDAQ:AKRX) announced on Friday that it will have to restate financials from 2014 due to accounting errors.